πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to CASI Pharmaceuticals, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

CASI Pharmaceuticals, Inc.

CASI Pharmaceuticals, Inc. logo
Market Cap: Low
Employees: Low

EVOMELA

CASI Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes therapeutics and pharmaceutical products focusing on markets in China, the United States, and internationally. Major products include EVOMELA and a pipeline with several investigational products targeting various cancers.

Tags: CAR-T, biopharmaceutical, cancer treatment, clinical trials, multiple myeloma, pharmaceutical, therapeutics

Symbol: CASI

Recent Price: $2.93

Industry: Biotechnology

CEO: Dr. Wei-Wu He Ph.D.

Sector: Healthcare

Employees: 176

Address: 9620 Medical Center Drive, Rockville, MD 20850

Phone: 240 864 2600

Last updated: 2024-12-31

Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

ELI-002

Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for cancer and other diseases, with its lead product ELI-002 targeting KRAS-driven cancers.

Tags: Biotechnology, Cancer Treatment, Clinical-stage, Immunotherapy, Vaccines

Symbol: ELTX

Recent Price: $5.00

Industry: Biotechnology

CEO: Mr. Robert T. Connelly

Sector: Healthcare

Employees: 32

Address: 451 D Street, Boston, MA 02210

Phone: 857-209-0050

Last updated: 2024-12-31

Evelo Biosciences, Inc.

Evelo Biosciences, Inc. logo
Market Cap: Lowest
Employees: Low

EDP1815

Evelo Biosciences, Inc. discovers and develops oral biologics for inflammatory diseases and cancer, with key products like EDP1815 in clinical trials.

Tags: biotechnology, cancer, clinical trials, inflammatory diseases, oral biologics

Symbol: EVLO

Recent Price: $0.00

Industry: Biotechnology

CEO: Mr. Craig R. Jalbert CIRA

Sector: Healthcare

Employees: 66

Address: 620 Memorial Drive, Cambridge, MA 02139

Phone: 617 577 0300

Last updated: 2024-12-31

Zentalis Pharmaceuticals, Inc.

Zentalis Pharmaceuticals, Inc. logo
Market Cap: Low
Employees: Low

ZN-c3, ZN-c5

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics for treating various cancers. Its leading product candidates include ZN-c3 and ZN-c5, which are in various phases of clinical trials targeting specific cancer types.

Tags: biopharmaceutical, cancer treatment, clinical trials, small molecule therapeutics

Symbol: ZNTL

Recent Price: $2.92

Industry: Biotechnology

CEO: Dr. Kimberly Lynn Blackwell M.D.

Sector: Healthcare

Employees: 124

Address: 1359 Broadway, New York, NY 10018

Phone: 212 433 3791

Last updated: 2024-12-31

Eli Lilly and Company

Eli Lilly and Company logo
Market Cap: Highest
Employees: Highest

Pharmaceuticals

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide, specializing in treatments for diabetes, cancer, and other conditions.

Tags: Biotechnology, Cancer Treatment, Diabetes, Pharmaceuticals

Symbol: LLY

Recent Price: $773.84

Industry: Drug Manufacturers - General

CEO: Mr. David A. Ricks

Sector: Healthcare

Employees: 43000

Address: Lilly Corporate Center, Indianapolis, IN 46285

Phone: 317 276 2000

Last updated: 2024-12-31

Checkpoint Therapeutics, Inc.

Checkpoint Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

Cosibelimab

Checkpoint Therapeutics, Inc. is a clinical-stage immunotherapy and targeted oncology company focused on acquiring, developing, and commercializing novel treatments for solid tumor cancers. Their lead product candidates include Cosibelimab, a fully-human monoclonal antibody, and other treatments for various cancer targets.

Tags: Antibody, Cancer Treatment, Cosibelimab, EGFR Inhibitor, Immunotherapy, Oncology

Symbol: CKPT

Recent Price: $3.35

Industry: Biotechnology

CEO: Mr. James F. Oliviero III, C.F.A.

Sector: Healthcare

Employees: 23

Address: 95 Sawyer Road, Waltham, MA 02453

Phone: 781 652 4500

Last updated: 2024-12-31

Curis, Inc.

Curis, Inc. logo
Market Cap: Lowest
Employees: Lowest

Emavusertib

Curis, Inc. is a biotechnology company focused on discovering and developing drug candidates for treating human cancers, with a range of clinical stage and pipeline products targeting lymphomas, leukemia, and solid tumors.

Tags: biotechnology, cancer treatment, clinical trials, drug development, oncology

Symbol: CRIS

Recent Price: $3.14

Industry: Biotechnology

CEO: Mr. James E. Dentzer

Sector: Healthcare

Employees: 49

Address: Building C, Lexington, MA 02421

Phone: 617 503 6500

Leadership

  • Martyn D. Greenacre, Chair of the Board
  • John Hohneker, M.D., Director
  • Kenneth I. Kaitin, Ph.D., Director
  • Anne E. Borgman, M.D., Director
  • Marc Rubin, M.D., Director
  • James Dentzer, Chief Executive Officer and Director

Last updated: 2024-12-31

CervoMed Inc.

CervoMed Inc. logo
Market Cap: Low
Employees: Lowest

neflamapimod

Cervo Med Inc. is a clinical-stage biotechnology company focused on developing and commercializing drug treatments for neurodegenerative diseases, including neflamapimod for conditions like dementia with Lewy bodies, Alzheimer's diseases, and brain stroke recovery.

Tags: Alzheimer's, biotechnology, brain stroke recovery, dementia, drug development, neurodegenerative diseases

Symbol: CRVO

Recent Price: $2.39

Industry: Biotechnology

CEO: Dr. John J. Alam M.D.

Sector: Healthcare

Employees: 8

Address: 20 Park Plaza, Boston, MA 02116

Phone: 617-744-4400

Last updated: 2024-12-31

Evoke Pharma, Inc.

Evoke Pharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

Gimoti

Evoke Pharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing treatments for gastroenterological disorders, primarily targeting symptoms of diabetic gastroparesis with its product Gimoti.

Tags: drug development, gastroenterology, gastroparesis, healthcare, pharmaceutical

Symbol: EVOK

Recent Price: $4.77

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Matthew J. D'Onofrio MBA

Sector: Healthcare

Employees: 4

Address: 420 Stevens Avenue, Solana Beach, CA 92075

Phone: 858 345 1494

Leadership

  • Matthew J. D’Onofrio, Chief Executive Officer
  • Mark Kowieski, CPA, Chief Financial Officer
  • Marilyn R. Carlson, D.M.D., M.D., Chief Medical Officer
  • Chris Quesenberry, Chief Commercial Officer
  • Cam L. Garner, Chairman
  • Todd C. Brady, M.D., Ph.D., Chief Executive Officer, President, and Director
  • Malcolm R. Hill, Pharm.D., Chief Development Officer
  • Kenneth J. Widder, M.D., Member of Board of Directors
  • Vickie W. Reed, Member of Board of Directors
  • David A. Gonyer, R.Ph., Member of Board of Directors

Last updated: 2024-12-31

Kala Pharmaceuticals, Inc.

Kala Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

KPI-012, EYSUVIS, INVELTYS

Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for eye diseases using proprietary mucus penetrating particles technology.

Tags: biopharmaceutical, corneal epithelial defects, dry eye disease, eye diseases, gene expression, mucus penetrating particles, ocular surgery, retinal diseases

Symbol: KALA

Recent Price: $6.87

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Mark T. Iwicki

Sector: Healthcare

Employees: 43

Address: 1167 Massachusetts Avenue, Arlington, MA 02476

Phone: 781 996 5252

Last updated: 2024-12-31

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated logo
Market Cap: High
Employees: Lowest

Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.

Tags: biopharmaceutical, commercial programs, disease treatment, medicine development, pharmaceutical technology

Symbol: LGND

Recent Price: $105.76

Industry: Biotechnology

CEO: Mr. Todd C. Davis Ph.D.

Sector: Healthcare

Employees: 58

Address: 5980 Horton Street, EmeryVille, CA 94608

Phone: 858 550 7500

Last updated: 2024-12-31

Longeveron Inc.

Longeveron Inc. logo
Market Cap: Lowest
Employees: Lowest

LOMECEL-B

Longeveron Inc. is a biotechnology company that develops cellular therapies for aging-related and life-threatening conditions. Its leading product, LOMECEL-B, undergoes clinical trials for various serious health indications.

Tags: LOMECEL-B, aging-related conditions, biotechnology, cellular therapies, clinical stage, clinical trials

Symbol: LGVN

Recent Price: $1.77

Industry: Biotechnology

CEO: Mr. Mohamed Wa'el Ahmed Hashad M.B.A.

Sector: Healthcare

Employees: 23

Address: 1951 NW 7th Avenue, Miami, FL 33136

Phone: 305 909 0840

Leadership

  • Wa'el Hashad, Chief Executive Officer
  • K. Chris Min, MD, Ph.D., Acting Chief Medical Officer
  • Joshua M. Hare, MD, FACC, FAHA, Chairman, Chief Science Officer
  • Lisa Locklear, Chief Financial Officer
  • Nataliya Agafonova, MD, Chief Medical Officer
  • James Clavijo, Acting Chief Financial Officer
  • Paul Lehr, JD, General Counsel and Secretary
  • Lisa McClain-Moss, Vice President, Manufacturing
  • Jerome Bailey, Vice President of Business Operations
  • Elly Ryu, Vice President & Corporate Controller
  • Brian Rash, Vice President of Research & Discovery
  • Mike Mannarino, Vice President and Corporate Controller
  • Tavara Andrews, Vice President & Corporate Controller
  • Anthony Oliva, Ph.D., Senior Scientist
  • Dan Gincel, Ph.D., Senior VP, Strategic Collaborations & Scientific Affairs
  • Dr. Kevin Ramdas, Director, Clinical Operations
  • Kwan-Hong Chris Min, Acting Chief Medical Officer
  • Donald M. Soffer, Board of Directors
  • Khoso Baluch, Independent Director
  • Jeffrey Pfeffer, Board of Directors
  • Richard Kender, Board of Directors
  • Neil E. Hare, JD, Board of Directors
  • Rock Soffer, Board of Directors
  • Douglas Losordo, MD, Board of Directors
  • Erin Borger, Board of Directors
  • Cathy Ross, Board of Directors
  • Ursula Ungaro, Board of Directors
  • Neha Motwani, Board of Directors
  • Roger Hajjar, MD, Board of Directors
  • Todd Girolamo, JD, MBA, Board of Directors

Last updated: 2024-12-31

MEI Pharma, Inc.

MEI Pharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

Zandelisib

MEI Pharma, Inc. is a late-stage pharmaceutical company focused on developing and commercializing therapies for cancer treatment, including Zandelisib and Voruciclib.

Tags: Voruciclib, Zandelisib, cancer therapy, clinical trials, oncology, pharmaceutical

Symbol: MEIP

Recent Price: $2.45

Industry: Biotechnology

CEO: Mr. Justin J. File

Sector: Healthcare

Employees: 28

Address: 11455 El Camino Real, San Diego, CA 92130

Phone: 858 369 7100

Last updated: 2024-12-31

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc. logo
Market Cap: High
Employees: Medium

Crysvita, Mepsevii, Dojolvi, Evkeeza, DTX401, DTX301

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on the development and commercialization of products for rare and ultra-rare genetic diseases worldwide.

Tags: Crysvita, Dojolvi, Evkeeza, Mepsevii, biopharmaceutical, gene therapy, genetic diseases, rare diseases

Symbol: RARE

Recent Price: $42.27

Industry: Biotechnology

CEO: Dr. Emil D. Kakkis M.D., Ph.D.

Sector: Healthcare

Employees: 1276

Address: 60 Leveroni Court, Novato, CA 94949

Phone: 415 483 8800

Last updated: 2024-12-31

Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc. logo
Market Cap: Low
Employees: Low

Tavalisse

Rigel Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases.

Tags: biotechnology, cancer, drug development, hematologic disorders, immune diseases

Symbol: RIGL

Recent Price: $16.47

Industry: Biotechnology

CEO: Mr. Raul R. Rodriguez

Sector: Healthcare

Employees: 147

Address: 1180 Veterans Boulevard, South San Francisco, CA 94080

Phone: 650 624 1100

Last updated: 2024-12-31

Cassava Sciences, Inc.

Cassava Sciences, Inc. logo
Market Cap: High
Employees: Lowest

simufilam

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead product candidate, simufilam, is a small molecule drug, recently completed Phase 2b clinical trial. The company also develops Sava Dx, a diagnostic to detect Alzheimer's disease.

Tags: Alzheimer's, Sava Dx, biotechnology, drug development, neurodegenerative diseases, simufilam

Symbol: SAVA

Recent Price: $2.40

Industry: Biotechnology

CEO: Mr. Richard Jon Barry

Sector: Healthcare

Employees: 29

Address: 7801 North Capital of Texas Highway, Austin, TX 78731

Phone: 512 501 2444

Last updated: 2024-12-31

Vericel Corporation

Vericel Corporation logo
Market Cap: High
Employees: Low

MACI, Epicel, NexoBrid

Vericel Corporation is a commercial-stage biopharmaceutical company focusing on the development, manufacture, and distribution of cellular therapies for sports medicine and burn care in the United States. Their products include MACI for cartilage repair and Epicel for burn treatment.

Tags: United States, autologous cell therapy, biopharmaceutical, burn care, cellular therapies, sports medicine

Symbol: VCEL

Recent Price: $55.30

Industry: Biotechnology

CEO: Mr. Dominick C. Colangelo Esq.

Sector: Healthcare

Employees: 314

Address: 64 Sidney Street, Cambridge, MA 02139

Phone: 617 588 5555

Last updated: 2024-12-31

Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

DANYELZA

Y-m Abs Therapeutics, Inc., is a commercial-stage biopharmaceutical company focused on developing and commercializing novel antibody-based therapeutic products for cancer treatment in the United States.

Tags: DANYELZA, antibody, biopharmaceutical, cancer treatment, clinical trials

Symbol: YMAB

Recent Price: $7.76

Industry: Biotechnology

CEO: Mr. Michael Rossi

Sector: Healthcare

Employees: 100

Address: 230 Park Avenue, New York, NY 10169

Phone: 646 885 8505

Leadership

  • Michael Rossi, President and Chief Executive Officer
  • Thomas Gad, Founder, Vice Chairman of the Board of Directors, Chief Business Officer
  • Torben Lund-Hansen, SVP, Chief Technical Officer
  • Peter Pfreundschuh, Chief Financial Officer
  • Vignesh Rajah, SVP, Chief Medical Officer
  • Joris Wilms, SVP, Chief Operating Officer
  • Sue Smith, SVP, Chief Commercial Officer
  • Norman LaFrance, Chief Development Officer
  • Johan Wedell-Wedellsborg, Chairman
  • Ashutosh Tyagi, M.D.,
  • James I. Healy, Chairman
  • David N. Gill,
  • Laura J. Hamill,
  • Mary Tagliaferri, M.D.,

Last updated: 2024-12-31

Catalent, Inc.

Catalent, Inc. logo
Market Cap: Highest
Employees: Highest

Drug and health product solutions

Catalent, Inc. develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products globally. It operates through segments like Biologics, Softgel and Oral Technologies, among others.

Tags: Biologics, Biotech, Drug Development, Gene Therapy, Health Products, Pharmaceuticals

Symbol: CTLT

Recent Price: $63.48

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Alessandro Maselli

Sector: Healthcare

Employees: 17000

Address: 14 Schoolhouse Road, Somerset, NJ 08873

Phone: 732 537 6200

Last updated: 2024-12-31

Exelixis, Inc.

Exelixis, Inc. logo
Market Cap: Highest
Employees: Medium

CABOMETYX, COMETRIQ, COTELLIC, MINNEBRO

Exelixis, Inc. is an oncology-focused biotechnology company that discovers, develops, and commercializes new medicines to treat cancers, primarily in the United States. Its products include CABOMETYX, COMETRIQ, COTELLIC, and MINNEBRO.

Tags: biotechnology, cancer treatment, oncology, pharmaceuticals

Symbol: EXEL

Recent Price: $33.70

Industry: Biotechnology

CEO: Dr. Michael M. Morrissey Ph.D.

Sector: Healthcare

Employees: 1310

Address: 1851 Harbor Bay Parkway, Alameda, CA 94502

Phone: 650 837 7000

Last updated: 2024-12-31